NSABP B-47: A Randomized Phase III Trial of Adjuvant Therapy Comparing Chemotherapy Alone (Six Cycles) of Docetaxel Plus Cyclophosphamide or Four Cycles of Doxorubicin Plus Cyclophosphamide Followed by Weekly Paclitaxel to Chemotherapy Plus Trastuzumab

CTO - 6723
Cancer - Breast
  1. Must be female at least 18 years of age
  2. Tumor must be unilateral invasive adenocarcinoma of the breast on histologic examination; all staging criteria must be met
  3. Patient must have undergone either a total mastectomy or breast conserving surgery
Tiffany Pearce